{"id":"https://openalex.org/W1978714492","doi":"https://doi.org/10.1248/bpb.25.1112","title":"Effect of Probucol on Cytochrome P450 Activities in Human Liver Microsomes.","display_name":"Effect of Probucol on Cytochrome P450 Activities in Human Liver Microsomes.","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W1978714492","doi":"https://doi.org/10.1248/bpb.25.1112","mag":"1978714492","pmid":"https://pubmed.ncbi.nlm.nih.gov/12186421"},"language":"en","primary_location":{"id":"doi:10.1248/bpb.25.1112","doi":"https://doi.org/10.1248/bpb.25.1112","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.25.1112","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/25/8/25_8_1112/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/bpb/25/8/25_8_1112/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021278273","display_name":"Ken Umehara","orcid":"https://orcid.org/0000-0002-8889-5552","observed_orcids":["https://orcid.org/0000-0002-8889-5552"]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ken Umehara","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113731784","display_name":"Yoshihiko Shimokawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiko Shimokawa","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083972551","display_name":"Gohachiro Miyamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Gohachiro Miyamoto","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I114030911"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114030911"],"apc_list":null,"apc_paid":null,"fwci":0.7084,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.64329535,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"25","issue":"8","first_page":"1112","last_page":"1114"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/probucol","display_name":"probucol","score":1.0},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.9860000014305115},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.8389999866485596},{"id":"https://openalex.org/keywords/human-liver-microsomes","display_name":"human liver microsomes","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cyp-isoforms","display_name":"CYP isoforms","score":0.7229999899864197},{"id":"https://openalex.org/keywords/ethoxyresorufin-o-deethylation","display_name":"7-ethoxyresorufin O-deethylation","score":0.9179999828338623},{"id":"https://openalex.org/keywords/coumarin-7-hydroxylation","display_name":"coumarin 7-hydroxylation","score":0.9380000233650208},{"id":"https://openalex.org/keywords/s-mephenytoin-4-hydroxylation","display_name":"S-mephenytoin 4'-hydroxylation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/chlorzoxazone-6-hydroxylation","display_name":"chlorzoxazone 6-hydroxylation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/testosterone-6beta-hydroxylation","display_name":"testosterone 6beta-hydroxylation","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.7089999914169312},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cyp2e1","display_name":"CYP2E1","score":0.7870000004768372},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.6669999957084656},{"id":"https://openalex.org/keywords/cyp2b6","display_name":"CYP2B6","score":0.7850000262260437},{"id":"https://openalex.org/keywords/cyp2a6","display_name":"CYP2A6","score":0.902999997138977},{"id":"https://openalex.org/keywords/cyp1a1-2","display_name":"CYP1A1/2","score":0.7789999842643738},{"id":"https://openalex.org/keywords/cholesterol-lowering-drugs","display_name":"cholesterol-lowering drugs","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C2781109383","wikidata":"https://www.wikidata.org/wiki/Q898497","display_name":"Hydroxylation","level":3,"score":0.7165629267692566},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.7122746109962463},{"id":"https://openalex.org/C2776658834","wikidata":"https://www.wikidata.org/wiki/Q3294630","display_name":"Chlorzoxazone","level":5,"score":0.705723226070404},{"id":"https://openalex.org/C196013638","wikidata":"https://www.wikidata.org/wiki/Q14874295","display_name":"CYP2A6","level":5,"score":0.6946784257888794},{"id":"https://openalex.org/C2776167589","wikidata":"https://www.wikidata.org/wiki/Q10354103","display_name":"Probucol","level":3,"score":0.6926789283752441},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.6849536299705505},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6622729897499084},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6573113799095154},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.6307182312011719},{"id":"https://openalex.org/C2776054734","wikidata":"https://www.wikidata.org/wiki/Q414275","display_name":"Tolbutamide","level":3,"score":0.5836881995201111},{"id":"https://openalex.org/C50605568","wikidata":"https://www.wikidata.org/wiki/Q14912267","display_name":"CYP2B6","level":5,"score":0.5591078400611877},{"id":"https://openalex.org/C115368759","wikidata":"https://www.wikidata.org/wiki/Q14916190","display_name":"CYP2C8","level":5,"score":0.5392192602157593},{"id":"https://openalex.org/C2776838488","wikidata":"https://www.wikidata.org/wiki/Q1175385","display_name":"Mephenytoin","level":5,"score":0.5253238677978516},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4422527849674225},{"id":"https://openalex.org/C86745063","wikidata":"https://www.wikidata.org/wiki/Q3737406","display_name":"CYP1A2","level":4,"score":0.4296317398548126},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.4144909977912903},{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.40743404626846313},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3694072961807251},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.31821611523628235},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2868781089782715},{"id":"https://openalex.org/C140027455","wikidata":"https://www.wikidata.org/wiki/Q14864434","display_name":"CYP2E1","level":4,"score":0.278960645198822},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.24159839749336243},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23616233468055725},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.17068541049957275},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.14425310492515564},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D011341","descriptor_name":"Probucol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1248/bpb.25.1112","doi":"https://doi.org/10.1248/bpb.25.1112","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.25.1112","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/25/8/25_8_1112/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:12186421","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12186421","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/bpb.25.1112","doi":"https://doi.org/10.1248/bpb.25.1112","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.25.1112","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/25/8/25_8_1112/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1978714492.pdf","grobid_xml":"https://content.openalex.org/works/W1978714492.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W939081374","https://openalex.org/W1566765557","https://openalex.org/W1816481860","https://openalex.org/W1907972556","https://openalex.org/W1921017818","https://openalex.org/W1956948916","https://openalex.org/W1968818951","https://openalex.org/W1981443123","https://openalex.org/W1984526747","https://openalex.org/W1986838867","https://openalex.org/W2000548860","https://openalex.org/W2003237988","https://openalex.org/W2005910570","https://openalex.org/W2014884679","https://openalex.org/W2032486494","https://openalex.org/W2046702624","https://openalex.org/W2046743025","https://openalex.org/W2048946635","https://openalex.org/W2065675076","https://openalex.org/W2065976317","https://openalex.org/W2130497556","https://openalex.org/W2131614625","https://openalex.org/W2165811356","https://openalex.org/W2183081955","https://openalex.org/W2274594089","https://openalex.org/W2399347989","https://openalex.org/W2410779580","https://openalex.org/W2416472979","https://openalex.org/W3175532480"],"related_works":["https://openalex.org/W2462097670","https://openalex.org/W1991543122","https://openalex.org/W3185682006","https://openalex.org/W1700334471","https://openalex.org/W2353169152","https://openalex.org/W2163536623","https://openalex.org/W2052271610","https://openalex.org/W2329532528","https://openalex.org/W7095514085","https://openalex.org/W1708423019"],"abstract_inverted_index":{"The":[0,32],"effects":[1,74],"of":[2],"probucol,":[3,94],"a":[4],"cholesterol-lowering":[5],"agent,":[6],"on":[7,75],"several":[8],"cytochrome":[9],"P450":[10],"(CYP)":[11],"isoform-specific":[12],"reactions":[13,37],"in":[14,26,29,40],"human":[15],"liver":[16],"microsomes":[17],"were":[18,38],"investigated":[19],"to":[20,89,104],"predict":[21],"drug":[22],"interactions":[23,108],"with":[24,109],"probucol":[25],"vivo":[27],"from":[28],"vitro":[30],"data.":[31],"following":[33],"eight":[34],"CYP":[35],"catalytic":[36],"used":[39],"this":[41],"study:":[42],"CYP1A1/2-mediated":[43],"7-ethoxyresorufin":[44],"O-deethylation,":[45],"CYP2A6-mediated":[46],"coumarin":[47],"7-hydroxylation,":[48],"CYP2B6-mediated":[49],"7-benzyloxyresorufin":[50],"O-debenzylation,":[51],"CYP2C8/9-mediated":[52],"tolbutamide":[53],"methylhydroxylation,":[54],"CYP2C19-mediated":[55],"S-mephenytoin":[56],"4'-hydroxylation,":[57],"CYP2D6-mediated":[58],"bufuralol":[59],"1'-hydroxylation,":[60],"CYP2E1-mediated":[61],"chlorzoxazone":[62],"6-hydroxylation,":[63],"and":[64,83],"CYP3A4-mediated":[65],"testosterone":[66],"6beta-hydroxylation.":[67],"Probucol":[68],"had":[69],"neither":[70],"stimulatory":[71],"nor":[72],"inhibitory":[73],"CYP1Al/2,":[76],"2A6,":[77],"2B6,":[78],"2C8/9,":[79],"2C19,":[80],"2D6,":[81],"2E1,":[82],"3A4":[84],"activities":[85],"at":[86,95],"concentrations":[87],"up":[88],"300":[90],"microM,":[91],"indicating":[92],"that":[93],"the":[96],"expected":[97],"therapeutic":[98],"concentrations,":[99],"would":[100],"not":[101],"be":[102],"predicted":[103],"cause":[105],"clinically":[106],"significant":[107],"other":[110],"CYP-metabolized":[111],"drugs.":[112]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}